Barclays Downgrades Aspen Aerogels to Equal-Weight, Lowers Price Target to $7
Benzinga Newsdesk 1 year ago
NewsDowngradesPrice TargetAnalyst Ratings
Barclays analyst David Anderson downgrades Aspen Aerogels (NYSE:ASPN) from Overweight to Equal-Weight and lowers the price target from $13 to $7.
Barclays analyst David Anderson downgrades Aspen Aerogels (NYSE:ASPN) from Overweight to Equal-Weight and lowers the price target from $13 to $7.